ESC 365 - Doctor Shafeeq Ahmed Mohammed

Speaker illustration

Doctor Shafeeq Ahmed Mohammed

University Hospital Zurich, Zurich (Switzerland)

Member of:

European Society of Cardiology

Presentations Articles

Targeting the histone methyltransferase SETD7 rescues diabetes-induced impairment of angiogenic response by transcriptional repression of semaphorin 3G

Event: ESC Congress 2024

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Epigenetic targets in cardiovascular disease

The BET protein inhibitor apabetalone (RVX-208) prevents doxorubicin-induced endothelial senescence

Event: ESC Congress 2024

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Session: Novel insights into ageing and senescence

Targeting the histone methyltransferase SETD7 rescues diabetes-induced impairment of angiogenic response by transcriptional repression of semaphorin 3G

Event: Frontiers in CardioVascular Biomedicine 2024

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Young Investigator Award I

Histone Mono-methylation by SETD7 Orchestrates Angiogenic Response in Diabetic Limb Ischemia

Event: ESC Congress 2023

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Epigenetics and cardiovascular diseases: bench to bedside

Genetic Deletion of Hepatic NCOR1 regulates the bile acid metabolism and leads to reduction in atherosclerosis

Event: ESC Congress 2023

Topic: Lipids, Metabolism

Session: Vascular disease and perturbed lipid metabolism

A chromatin signature by the methyltransferase SETD7 orchestrates angiogenic response in diabetic limb ischemia

Event: ESC Congress 2022

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Metabolic control of angiogenesis

Targeting Neurofibromin 2 (NF2) Prevents Endothelial Dysfunction in Obesity: A Study in Mice and Humans

Event: ESC Congress 2022

Topic: Signal Transduction, Mechanotransduction

Session: Metabolic syndrome and vascular dysfunction

Pharmacological blockade of histone methyltransferase SETD7 restores angiogenic response in experimental diabetes

Event: ESC Congress 2021 - The Digital Experience

Topic: Genetics, Epigenetics, ncRNA

Session: Congress committee e-posters choice in basic science

The BET protein inhibitor apabetalone (RVX-208) restores angiogenic response in type 1 and type 2 diabetes by transcriptional regulation of thrombospondin-1

Event: ESC Congress 2021 - The Digital Experience

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Basic science e-posters

A chromatin signature by the methyltransferase SETD7 regulates semaphorin-3G transcription and angiogenic response in diabetes: insights for personalized epigenetic therapies

Event: ESC Congress 2020

Topic: Genetics, Epigenetics, ncRNA

Session: Genetics

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources